XOMA Royalty Corporation (XOMA) - Total Liabilities
Based on the latest financial reports, XOMA Royalty Corporation (XOMA) has total liabilities worth $158.96 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See XOMA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
XOMA Royalty Corporation - Total Liabilities Trend (1985–2025)
This chart illustrates how XOMA Royalty Corporation's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are XOMA Royalty Corporation's assets to evaluate the company's liquid asset resilience ratio.
XOMA Royalty Corporation Competitors by Total Liabilities
The table below lists competitors of XOMA Royalty Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Allied Supreme Corp
TW:4770
|
Taiwan | NT$1.91 Billion |
|
Lingyuan Iron & Steel Co Ltd
SHG:600231
|
China | CN¥11.91 Billion |
|
Zee Entertainment Enterprises Limited
NSE:ZEEL
|
India | Rs24.87 Billion |
|
Beijing Haitian Ruisheng Science Technology Ltd
SHG:688787
|
China | CN¥116.34 Million |
|
MRV Engenharia e Participações S.A
SA:MRVE3
|
Brazil | R$22.36 Billion |
|
Riskified Ltd
NYSE:RSKD
|
USA | $102.65 Million |
|
KSL Holdings Bhd
KLSE:5038
|
Malaysia | RM1.53 Billion |
|
NICE Information Service Co. Ltd
KQ:030190
|
Korea | ₩128.37 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down XOMA Royalty Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see XOMA asset base.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how XOMA Royalty Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for XOMA Royalty Corporation (1985–2025)
The table below shows the annual total liabilities of XOMA Royalty Corporation from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $168.74 Million | +21.08% |
| 2024-12-31 | $139.36 Million | -4.28% |
| 2023-12-31 | $145.58 Million | +789.42% |
| 2022-12-31 | $16.37 Million | -33.70% |
| 2021-12-31 | $24.69 Million | -36.48% |
| 2020-12-31 | $38.86 Million | -24.89% |
| 2019-12-31 | $51.74 Million | +14.97% |
| 2018-12-31 | $45.00 Million | +14.95% |
| 2017-12-31 | $39.15 Million | -48.41% |
| 2016-12-31 | $75.89 Million | -1.69% |
| 2015-12-31 | $77.19 Million | -10.80% |
| 2014-12-31 | $86.53 Million | -37.64% |
| 2013-12-31 | $138.77 Million | +64.79% |
| 2012-12-31 | $84.21 Million | +33.61% |
| 2011-12-31 | $63.02 Million | +24.41% |
| 2010-12-31 | $50.66 Million | +43.52% |
| 2009-12-31 | $35.30 Million | -64.19% |
| 2008-12-31 | $98.57 Million | +16.66% |
| 2007-12-31 | $84.50 Million | -34.83% |
| 2006-12-31 | $129.65 Million | +39.04% |
| 2005-12-31 | $93.25 Million | +31.58% |
| 2004-12-31 | $70.87 Million | +0.33% |
| 2003-12-31 | $70.64 Million | -15.05% |
| 2002-12-31 | $83.15 Million | +14.70% |
| 2001-12-31 | $72.49 Million | +34.73% |
| 2000-12-31 | $53.80 Million | +19.03% |
| 1999-12-31 | $45.20 Million | +21.83% |
| 1998-12-31 | $37.10 Million | +10.42% |
| 1997-12-31 | $33.60 Million | +46.09% |
| 1996-12-31 | $23.00 Million | +63.12% |
| 1995-12-31 | $14.10 Million | -25.40% |
| 1994-12-31 | $18.90 Million | +20.38% |
| 1993-12-31 | $15.70 Million | -24.52% |
| 1992-12-31 | $20.80 Million | +5.05% |
| 1991-12-31 | $19.80 Million | -71.95% |
| 1990-12-31 | $70.60 Million | -15.35% |
| 1989-12-31 | $83.40 Million | +230.95% |
| 1988-12-31 | $25.20 Million | -10.00% |
| 1987-12-31 | $28.00 Million | -20.90% |
| 1986-12-31 | $35.40 Million | +1866.67% |
| 1985-12-31 | $1.80 Million | -- |
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with co… Read more